Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone AL Feldman, DA Arber, S Pittaluga, A Martinez, JS Burke, M Raffeld, ... Blood, The Journal of the American Society of Hematology 111 (12), 5433-5439, 2008 | 334 | 2008 |
Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden FLT3-ITD mutation and concomitant NPM1 mutation: relevance to post … M Pratcorona, S Brunet, J Nomdedéu, JM Ribera, M Tormo, R Duarte, ... Blood, The Journal of the American Society of Hematology 121 (14), 2734-2738, 2013 | 311 | 2013 |
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma S Mercadal, J Briones, B Xicoy, C Pedro, L Escoda, C Estany, M Camos, ... Annals of Oncology 19 (5), 958-963, 2008 | 240 | 2008 |
Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (“accelerated” chronic lymphocytic leukemia) with aggressive … E Giné, A Martinez, N Villamor, A López-Guillermo, M Camos, D Martinez, ... Haematologica 95 (9), 1526, 2010 | 216 | 2010 |
Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome A Garcia-Herrera, L Colomo, M Camós, J Carreras, O Balague, ... Journal of clinical oncology 26 (20), 3364-3371, 2008 | 166 | 2008 |
Gene Expression Profiling of Acute Myeloid Leukemia with Translocation t(8;16)(p11;p13) and MYST3-CREBBP Rearrangement Reveals a Distinctive Signature with a … M Camós, J Esteve, P Jares, D Colomer, M Rozman, N Villamor, D Costa, ... Cancer research 66 (14), 6947-6954, 2006 | 165 | 2006 |
Premature aging and immune senescence in HIV-infected children K Gianesin, A Noguera-Julian, M Zanchetta, P Del Bianco, MR Petrara, ... Aids 30 (9), 1363-1373, 2016 | 98 | 2016 |
Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ... Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019 | 97 | 2019 |
Type I MOZ/CBP (MYST3/CREBBP) is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation M Rozman, M Camós, D Colomer, N Villamor, J Esteve, D Costa, A Carrió, ... Genes, Chromosomes and Cancer 40 (2), 140-145, 2004 | 97 | 2004 |
Predictive value of Follicular Lymphoma International Prognostic Index (FLIPI) in patients with follicular lymphoma at first progression S Montoto, A Lopez-Guillermo, A Altes, G Perea, A Ferrer, M Camós, ... Annals of oncology 15 (10), 1484-1489, 2004 | 95 | 2004 |
Imatinib mesylate therapy of chronic phase chronic myeloid leukemia resistant or intolerant to interferon: results and prognostic factors for response and progression-free … F Cervantes, JC Hernández-Boluda, JL Steegmann, E Conde, ... haematologica 88 (10), 1117-1122, 2003 | 82 | 2003 |
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy E Barragán, P Montesinos, M Camos, M González, MJ Calasanz, ... Haematologica 96 (10), 1470, 2011 | 75 | 2011 |
ZAP-70 expression in normal pro/pre B cells, mature B cells, and in B-cell acute lymphoblastic leukemia M Crespo, N Villamor, E Giné, A Muntañola, D Colomer, T Marafioti, ... Clinical cancer research 12 (3), 726-734, 2006 | 71 | 2006 |
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia M Maffioli, M Camós, A Gaya, JC Hernández-Boluda, A Álvarez-Larrán, ... Leukemia research 35 (8), 1014-1019, 2011 | 69 | 2011 |
Acute myeloid leukemia with translocation (8; 16)(p11; p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene M Diaz-Beya, A Navarro, G Ferrer, T Diaz, B Gel, M Camos, M Pratcorona, ... Leukemia 27 (3), 595-603, 2013 | 66 | 2013 |
Grupo Cooperativo Para el Estudio y Tratamiento de las Leucemias Agudas Mieloblásticas. Favorable outcome of patients with acute myeloid leukemia harboring a low-allelic burden … M Pratcorona, S Brunet, J Nomdedéu, JM Ribera, M Tormo, R Duarte, ... Blood 121 (14), 2734-2738, 2013 | 63 | 2013 |
Structural and functional effects of hereditary hemolytic anemia-associated point mutations in the alpha spectrin tetramer site M Gaetani, S Mootien, S Harper, PG Gallagher, DW Speicher Blood, The Journal of the American Society of Hematology 111 (12), 5712-5720, 2008 | 55 | 2008 |
Survival after progression in patients with follicular lymphoma: analysis of prognostic factors S Montoto, A Lopez-Guillermo, A Ferrer, M Camós, A Alvarez-Larran, ... Annals of oncology 13 (4), 523-530, 2002 | 55 | 2002 |
The transcriptional repressor HDAC7 promotes apoptosis and c-Myc downregulation in particular types of leukemia and lymphoma B Barneda-Zahonero, O Collazo, A Azagra, I Fernández-Duran, ... Cell death & disease 6 (2), e1635-e1635, 2015 | 52 | 2015 |
Activated KRAS cooperates with MLL-AF4 to promote extramedullary engraftment and migration of cord blood CD34+ HSPC but is insufficient to initiate leukemia C Prieto, RW Stam, A Agraz-Doblas, P Ballerini, M Camos, J Castaño, ... Cancer Research 76 (8), 2478-2489, 2016 | 50 | 2016 |